Stay updated on Amivantamab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Colorectal Cancer Clinical Trial page.

Latest updates to the Amivantamab in Colorectal Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA Madrid site entry was added with postal code 28009, and the Madrid site at 28007 was removed; the page revision was updated to v3.6.6 with the corresponding dates (2026-08-28 addition, 2026-08-27 update).SummaryDifference0.2%

- Check19 days agoChange DetectedA new line '2023 ( U.S. NIH Grant/Contract )' was added, indicating NIH funding for the study. This adds funding attribution to the record without changing the study design or eligibility.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page shows Revision: v3.6.5 instead of v3.6.4, indicating a small backend/template update without changing the study details.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling a small update to the page or underlying system without altering the study details.SummaryDifference0.0%

- Check69 days agoChange DetectedEnrollment status was updated from Active, not recruiting to Completed, indicating that patient enrollment for the study has finished. This reflects a lifecycle shift and informs potential participants and sites that recruitment is no longer open.SummaryDifference0.2%

- Check76 days agoChange DetectedFinal JCO OrigAMI-1 publication citation with full bibliographic details is added to the Publications section, replacing the earlier online-ahead-of-print entry. The record’s revision tag is updated to v3.6.3, removing the previous v3.6.0 reference.SummaryDifference0.1%

Stay in the know with updates to Amivantamab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Colorectal Cancer Clinical Trial page.